EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation
Targeted Oncology · 2024
DOI: 10.1007/s11523-024-01042-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Targeted Oncology, 2024. Verfasst von Ruiying Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No. 241, West Huai Hai Road, Xv Hui District, Sha…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Adenocarcinoma. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Tsung-Dao Lee Institute, Shanghai Jiao Tong University, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No. 241, West Huai Hai Road, Xv Hui District, Shanghai, 200030, China.
- Department of Pulmonary, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No. 241, West Huai Hai Road, Xv Hui District, Shanghai, 200030, China.
- Department of Pulmonary, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No. 241, West Huai Hai Road, Xv Hui District, Shanghai, 200030, China. tianqing_chu@126.com.
- Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No. 241, West Huai Hai Road, Xv Hui District, Shanghai, 200030, China. ychan@cmu.edu.cn.
ORCID-Profile: Yuchen Han
Förderung
- Tsung-Dao Lee Institute, Shanghai Jiao Tong University
- National Natural Science Foundation of China
Zitieren
APA
Zhao, R., Li, J., Guo, L., Xiang, C., Chen, S., Zhao, J., Shao, J., Zhu, L., Ye, M., Qin, G., Chu, T., & Han, Y. (2024). EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation. Targeted Oncology. https://doi.org/10.1007/s11523-024-01042-3
Vancouver
Zhao R, Li J, Guo L, Xiang C, Chen S, Zhao J, et al. EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation. Targeted Oncology. 2024. doi:10.1007/s11523-024-01042-3
BibTeX
@article{Zhao2024,
author = {Zhao, Ruiying and Li, Jiaqi and Guo, Lianying and Xiang, Chan and Chen, Shengnan and Zhao, Jikai and Shao, Jinchen and Zhu, Lei and Ye, Min and Qin, Gang and Chu, Tianqing and Han, Yuchen},
title = {EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation},
journal = {Targeted Oncology},
year = {2024},
doi = {10.1007/s11523-024-01042-3}
}
EUVIMED